How the DH-8000 Automates the Diagnostic Bottleneck

DH-8000 Fully Automated Hematology Analysis Line

Laboratories processing thousands of hematology samples daily face a familiar friction: the gap between analysis speed and manual review. The DH-8000 collapses that gap by combining blood cell analysis, automated recheck, slide preparation, and infection marker testing into a single, conveyor-driven line.

The system integrates AI-assisted interpretation to flag abnormal results and prioritize rechecks, reducing the cognitive load on technicians. It also measures key infection biomarkers — CRP, SAA, PCT, and IL-6 — on the same platform, eliminating the need for separate immunoassay runs.

This matters because turnaround time for a complete blood count with infection markers often determines patient triage in emergency and outpatient settings. The DH-8000’s modular layout allows hospitals to scale capacity without reconfiguring floor plans, a practical advantage in space-constrained clinical labs.

China’s in vitro diagnostics sector has shifted from importing integrated lines to building them domestically. The DH-8000 reflects a mature supply chain capable of combining optics, fluidics, and software into a single product — a sign that local manufacturers now compete on workflow design, not just component assembly.

For procurement teams, the calculation is no longer just unit cost. It is whether a single vendor can replace three or four standalone instruments while maintaining throughput. The DH-8000’s real test is in daily operation — handling high sample volumes without cascading failures.

Automation in diagnostics is rarely about replacing humans. It is about freeing them to interpret what machines flag.

Why it matters:
Labs evaluating the DH-8000 should benchmark it against their existing workflow fragmentation. The system’s value lies less in raw speed and more in reducing the handoffs between analyzers — a hidden driver of errors and delays.

View Product →